7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18001637 | DETERGENT AND METHOD FOR PURIFYING A BIOTHERAPEUTIC | SWIFT, CANDICE LEE | 1657 | Final Rejection | Jul 14, 2023 |
| 18177387 | OPTIMIZED RATIOS OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS | BRADLEY, CHRISTINA | 1654 | Final Rejection | Mar 02, 2023 |
| 17997376 | COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICALLY ACTIVE AGENTS | ESPINOSA, CLAUDIA EDILMA | 1654 | Non-Final OA | Oct 28, 2022 |
| 17907683 | STABILIZED IGG4 ANTIBODIES AND USES THEREOF | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Sep 29, 2022 |
| 17801670 | FORMULATIONS OF ANTI-ENDOTHELIAL LIPASE ANTIBODIES | CHANDRA, GYAN | 1674 | Non-Final OA | Aug 23, 2022 |
| 17783463 | Compositions and Methods of Treating Cancer with Chimeric Antigen Receptors Targeting Glypican 3 | HILL, KEVIN KAI | 1638 | Non-Final OA | Jun 08, 2022 |
| 17775143 | ENDOTHELIAL LIPASE ANTIBODIES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | WEN, SHARON X | 1641 | Final Rejection | May 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial